Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients









 中文 EN

ACADEMIC HISKY

MAFLD Assessment of liver health Viral hepatitis Liver Cancer and Cirrhosis Evaluate the efficacy of medication Others

Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients

Ou Xiaojuan, Jia Jidong, et al. Chin J Hepatol, 2015, 23(2)

Objective

•To perform a comparative assessment of the performance of FibroTouch and FibroScan in patients with hepatitis B.

Methods

•211 patients with hepatitis B, including cases of CHB and compensated cirrhosis.
•The patients underwent FibroScan testing (group 1) and FibroTouch testing (group 3), after which the operator examined a time-motion ultrasound image from the FibroScan test and located a specific liver portion for focused FibroTouch testing (group 2).

Figures & Tables

Results

•The values of liver stiffness were 5.30 (4.30, 8.65) in group1, 6.10 (4.70, 8.90) in group 2, and 5.70 (4.50, 8.00) in group 3 (all P < 0.05); the Pearson correlation coefficients were all > 0.8 (p < 0.05) and there was no statistically significant difference found between the results from FibroScan and FibroTouch.
•The values of liver stiffness were significantly different between the CHB patients and the compensated cirrhosis patients (P < 0.05).
•The rates of successful detection were 100% for FibroTouch and 97% for FibroScan.

Conclusion

•FibroTouch and FibroScan have good consistency in the evaluation of the degree of liver fibrosis.
•FibroTouch has a higher rate of successful detection than FibroScan.

If you need more academic materials, please contact us.